Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

The phase III ESCORT-NEO trial evaluated camrelizumab in combination with chemotherapy versus chemotherapy alone in the ...

Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

The generic drugmaker was the top loser on the Nifty Pharma index and the benchmark Nifty 50 index. "The drop in shares comes ...

Unusual total active option classes on open include: B2Gold ( BTG ), Verizon ( VZ ), Zscaler ( ZS ), American Express ( AXP ), Mastercard ( MA ), KE Holdings ( BEKE ), Novo Nordisk ( NVO ), Microchip ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Results of 3 trials revealed that omitting transplant did not impact progression or survival outcomes for pediatric, ...

DelveInsight's report on Alpha Thalassemia provides a comprehensive analysis of the epidemiology and <a target=_blank href= ...

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...

The Board also approved a Miss. State career center funded through the U.S. Department of Education Rehabilitation Services ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...